Carillon Tower Advisers’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-359,748
| Closed | -$22.3M | – | 477 |
|
|
2019
Q3 | $22.3M | Hold |
359,748
| – | – | 0.16% | 230 |
|
|
2019
Q2 | $25.6M | Hold |
359,748
| – | – | 0.18% | 211 |
|
|
2019
Q1 | $28.2M | Hold |
359,748
| – | – | 0.2% | 192 |
|
|
2018
Q4 | $30.5M | Hold |
359,748
| – | – | 0.26% | 154 |
|
|
2018
Q3 | $61.6M | Hold |
359,748
| – | – | 0.44% | 67 |
|
|
2018
Q2 | $46.5M | Hold |
359,748
| – | – | 0.37% | 90 |
|
|
2018
Q1 | $35.9M | Hold |
359,748
| – | – | 0.28% | 118 |
|
|
2017
Q4 | $30.7K | Buy |
+359,748
| New | +$30.7K | 0.33% | 109 |
|